Discussing quality-of-life issues with a patient newly diagnosed with prostate cancer.
BACKGROUND
A 66-year-old man with hypertension, hyperlipidemia, and benign prostatic hyperplasia presented for evaluation of an elevated PSA level of 6.2 ng/ml.


METHODS
Transrectal ultrasound-guided 12-core prostate needle biopsy.


METHODS
Clinically localized, clinical stage T1c adenocarcinoma of the prostate.


RESULTS
Following a full discussion of the risks and benefits of his treatment options, including quality-of-life sequelae, the patient opted for radical prostatectomy.
Gore
John L
JL
Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA 90095, USA. jgore@mednet.ucla.edu
Penson
David F
DF
Litwin
Mark S
MS
D000230:Adenocarcinoma / Q000523:psychology* / Q000601:surgery; D000368:Aged; D001706:Biopsy; D006801:Humans; D008297:Male; D010817:Physician-Patient Relations; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000523:psychology*; D011471:Prostatic Neoplasms / Q000523:psychology* / Q000601:surgery; D011788:Quality of Life
D017430:Prostate-Specific Antigen